DrugPatentWatch Archives
Click here to return to the current data set
|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Generic Name: amikacin sulfate
Summary for Generic Name: amikacin sulfate
| |||||||||||||
Clinical Trials for: amikacin sulfatePharmacokinetics of Nebulized Amikacin in Patients With Pneumonia Undergoing Mechanical Ventilation Status: Recruiting Condition: Ventilator Associated Pneumonia Impact of Imipenem With Amikacin Pharmacokinetic and Pharmacodynamic Status: Completed Condition: Ventilator Associated Pneumonia Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia Status: Completed Condition: Pneumonia A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS) Status: Completed Condition: Pneumonia Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease Status: Withdrawn Condition: Pulmonary Non-tuberculous Mycobacterial Lung Disease Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children Status: Completed Condition: Neutropenia; Cancer; Fever A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals. Status: Completed Condition: Mycobacterium Avium-intracellulare Infection; HIV Infections Inhaled Amikacin Solution BAY41-6551 as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia Status: Recruiting Condition: Pneumonia, Bacterial Amikacin Penetration Into the Cerebrospinal Fluid Status: Withdrawn Condition: Gram Negative Meningitis; Post Traumatic Bacterial Meningitis Safety, Tolerability and Pharmacokinetics of Aerosolized Amikacin in Intubated and Mechanically-ventilated Patients With Nosocomial Pneumonia Status: Completed Condition: Pneumonia Courtesy of ClinicalTrials.org See more clinical trials for this drug | |||||||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Patent Expiration | Exclusivity Expiration | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE; INJECTION | 063265 | Nov 30, 1994 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbott | AMIKACIN SULFATE | amikacin sulfate | INJECTABLE; INJECTION | 063266 | Oct 31, 1994 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Apothecon | AMIKIN | amikacin sulfate | INJECTABLE; INJECTION | 050495 | Approved Prior to Jan 1, 1982 | DISCN | No | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Apothecon | AMIKIN | amikacin sulfate | INJECTABLE; INJECTION | 062311 | Approved Prior to Jan 1, 1982 | RX | Yes | <disabled> | <disabled> | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc